“…Our data indicate that heart muscle responds to moderate (therapeutic) doses of digitalis in hypothyroidism as well as hyperthyroidism, thus supporting a few clinical observations that the failing myocardium in hypothyroidism 18 and hyperthyroidism 19 "" 21 is, in fact, strengthened by digitalis. Regarding the digitalis requirement in treatment of atrial fibrillation in thyroid disorders reference should be made to the experimental work by Frye and Braunwald.…”
Section: Discussionsupporting
confidence: 86%
“…The animals were given food ad libitum. Studies were done after nine to eleven days of treatment (18)(19)(20)(21)(22)(23)(24) hours after the last thyroxine injection). Serum potassium levels were determined with a flame photometer before and at the conclusion of the treatment.…”
Ouabain-induced changes in cardiac contractile force and differences in the amount of ouabain required to induce arrhythmias and to produce death were evaluated in normal, thyroidectomized and thyroxine-treated dogs. It was found, that ouabain, following alterations in thyroid function, still substantially augmented cardiac contractile force in anesthetized open-chest dogs. In both the hypothyroid and the hyperthyroid animals a moderate dose of ouabain produced an increase in contractile force of approximately the same extent as in the euthyroid animals, although of slower onset in the hypothyroid dogs. Larger doses of ouabain caused a smaller positive inotropic response. in hyperthyroid dogs than in euthyroid and hypothyroid animals. Changes in thyroid function increased the arrhythmia-producing and the lethal dose of ouabain, which in the hyperthyroid dogs may have been due to the markedly elevated heart rate.
“…Our data indicate that heart muscle responds to moderate (therapeutic) doses of digitalis in hypothyroidism as well as hyperthyroidism, thus supporting a few clinical observations that the failing myocardium in hypothyroidism 18 and hyperthyroidism 19 "" 21 is, in fact, strengthened by digitalis. Regarding the digitalis requirement in treatment of atrial fibrillation in thyroid disorders reference should be made to the experimental work by Frye and Braunwald.…”
Section: Discussionsupporting
confidence: 86%
“…The animals were given food ad libitum. Studies were done after nine to eleven days of treatment (18)(19)(20)(21)(22)(23)(24) hours after the last thyroxine injection). Serum potassium levels were determined with a flame photometer before and at the conclusion of the treatment.…”
Ouabain-induced changes in cardiac contractile force and differences in the amount of ouabain required to induce arrhythmias and to produce death were evaluated in normal, thyroidectomized and thyroxine-treated dogs. It was found, that ouabain, following alterations in thyroid function, still substantially augmented cardiac contractile force in anesthetized open-chest dogs. In both the hypothyroid and the hyperthyroid animals a moderate dose of ouabain produced an increase in contractile force of approximately the same extent as in the euthyroid animals, although of slower onset in the hypothyroid dogs. Larger doses of ouabain caused a smaller positive inotropic response. in hyperthyroid dogs than in euthyroid and hypothyroid animals. Changes in thyroid function increased the arrhythmia-producing and the lethal dose of ouabain, which in the hyperthyroid dogs may have been due to the markedly elevated heart rate.
“…Kraus, Brown,57 Elliott,58 Plummer,59 Taussig, 60 Barr,61 Federn, 62 Krumbhaar,31 White,32 Kerr and Hensel, 34 Boothby,27 and others say that the blood-pressure is usually high, and that there is in most cases a high pulse pressure.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.